Successfully treatment of PLZF-RARα positive acute promyelocytic leukemia by Venetoclax combining with decitabine: a case report and literature review

Successfully treatment of PLZF-RARα positive acute promyelocytic leukemia by Venetoclax combining with decitabine: a case report and literature review

Introduction: Acute promyelocytic leukemia (APL) is mainly due to the chromosome translocation t(15; 17) (q22; q12), leading to the formation of PML-RARα fusion protein. However, some patients carried rare translocation involving RARα gene, and they were referred to as variant APL caused by the RAR...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ziwei Zhou, Erling Chen, Jiqian Jiang, Lei Xue, Lijun Zhu, Xing Hu, Yingqiao Zhu, Changcheng Zheng, Juan Tong
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Hematology
Subjects:	Acute promyelocytic leukemia (APL) case report PLZF-RARα Venetoclax t(11, 17) (q23; q21) hypomethylating agents
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2024.2399362
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DISTRIBUTION OF DIFFERENT PML/RARΑ BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
by: Tathagata Chatterjee, et al.
Published: (2013-12-01)

Effective treatment of peritoneal myeloid sarcoma with decitabine and venetoclax: A case report
by: Kavya Sudireddy, et al.
Published: (2025-01-01)

Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report
by: Xianfeng Ouyang, et al.
Published: (2025-05-01)

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
by: Yunshuo Xiao, et al.
Published: (2024-12-01)

The Role of Plzf in Spermatogonial Stem Cell Maintenance and Differentiation: Mapping the Transcriptional Dynamics and Key Interactions
by: Nima Ghasemi, et al.
Published: (2024-11-01)

Pattern of Expression of PML-RARα Transcripts in Acute Promyelocytic Leukemia Patients and Its Correlation with Overall Survival: A Retrospective Study from Western India
by: Shweta Gondha, et al.
Published: (2025-06-01)

HIF factors cooperate with PML‐RARα to promote acute promyelocytic leukemia progression and relapse
by: Nadia Coltella, et al.
Published: (2014-04-01)

Efficacy and safety of venetoclax and azacitidine for acute myeloid leukemia in China: a real-world single-center study
by: Jie-Fei Bai, et al.
Published: (2025-06-01)

Impact of KIT mutation on efficacy of venetoclax and hypomethylating agents in newly diagnosed acute myeloid leukemia
by: Wenxiu Shu, et al.
Published: (2025-05-01)

Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1‐Mutated Acute Myeloid Leukemia
by: Yiming Cai, et al.
Published: (2025-07-01)

Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study
by: Ji-Xin Tian, et al.
Published: (2025-07-01)

Older Jehovah’s Witnesses with Acute Myeloid Leukemia: Hypomethylating Agents and Venetoclax as a Transfusion-Sparing Approach
by: Aditi Sharma, et al.
Published: (2025-06-01)

Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement
by: Andrius Žučenka, et al.
Published: (2025-03-01)

Venetoclax and hypomethylating agents versus induction chemotherapy for newly diagnosed acute myeloid leukemia patients: a systematic review and meta-analysis
by: Yun Liu, et al.
Published: (2025-05-01)

Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities
by: Leiming Xia, et al.
Published: (2025-07-01)

Early RSV infection aggravates asthma-related Th2 responses by increasing the number of CD4<sup>+</sup> TRM cells through upregulation of PLZF
by: Zhang Meng, et al.
Published: (2024-12-01)

Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience
by: M. A. Granatkin, et al.
Published: (2023-03-01)

PLZF-expressing CD4+ T cells promote tissue-resident memory T cells in breaking immune tolerance in allergic asthma via IL-15/IL-15Rα signaling
by: Meng Zhang, et al.
Published: (2025-03-01)

Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia
by: E. V. Usikova, et al.
Published: (2023-01-01)

Co-occurrence of AIDS and acute promyelocytic leukemia: a case report and review of the literature
by: Cheng Ai, et al.
Published: (2025-07-01)

COVID-19 impacts on Amazon deforestation
by: Jerico Fiestas-Flores, et al.
Published: (2025-06-01)

Comparative efficacy and safety in low-intensity treatment for acute myeloid leukemia in older patients: a systematic review and network meta-analysis
by: Wenze Li, et al.
Published: (2025-04-01)

Clean energy adoption, industrialization and sustainable development: A system GMM approach
by: Yan Luan, et al.
Published: (2025-05-01)

Fiscal policy and deforestation
by: Luccas Assis Attílio, et al.
Published: (2024-12-01)

MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
by: Francesco Lococo, et al.
Published: (2013-06-01)

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.
by: Charicleia Kelaidi, et al.
Published: (2011-09-01)

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.
by: Lionel Ades, et al.
Published: (2011-01-01)

Acute promyelocytic leukemia lacking t(15;17): Molecular evidence of atypical PML/RAR-α transcriptional variant by gene sequencing
by: Đorđević Vesna, et al.
Published: (2020-01-01)

Venetoclax for an ATRA and ATO resistance acute promyelocytic leukemia patient with TNRC18::RARA fusion gene
by: Weina Li, et al.
Published: (2024-01-01)

The path to green economy: Do environmental taxes and renewable energy transition matter in OECD countries?
by: Sodiq Arogundade, et al.
Published: (2024-12-01)

VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review)
by: T. E. Byalik
Published: (2018-07-01)

The effect of fire-induced forest-degradation on rainfall: A causal inference analysis of the case of the Brazilian Amazon
by: Thiago F․ Morello R․ Silva
Published: (2024-12-01)

Basophils in Acute Promyelocytic Leukemia: Clonality or Reactiveness?
by: Xue Li, et al.
Published: (2025-06-01)

A Life-Threatening Complication During the Fourth Pregnancy Due to Acute Promyelocytic Leukemia: A Case Report
by: Ismy Azizah Sisnawati, et al.
Published: (2024-04-01)

WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα
by: Zhenyuan Qian, et al.
Published: (2024-12-01)

MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
by: Melanie Joannides, et al.
Published: (2011-10-01)

Predictive Factors of Fatal Bleeding in Pediatric Acute Promyelocytic Leukemia (APL)
by: Rabiha Manzoor, et al.
Published: (2025-04-01)

Deluging thrombosis: An unusual presentation of acute promyelocytic leukemia
by: Aditya Jandial, et al.
Published: (2020-01-01)

PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
by: Laura Russo, et al.
Published: (2011-01-01)

CLINICAL FEATURES AND CLINICAL OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED AT CAIRO NATIONAL CANCER INSTITUTE IN EGYPT
by: Tamer M Fouad, et al.
Published: (2011-01-01)